Why is Jagsonpal Pharma falling/rising?

As of 15-Jul, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 246.60, which reflects a decrease of Rs 6.85 or 2.7%. Today's price summary indicates that the stock has underperformed its sector by 3.95% and has fallen after two consecutive days of gains. The stock reached an intraday high of Rs 258.65 but also touched a low of Rs 245, indicating volatility. Despite this decline, the stock has shown strong performance over the past year, with a return of 69.83%, and has outperformed the BSE500 index over various periods, including a remarkable 1422.22% increase over the last five years. The company has also reported positive financial growth, with a significant increase in operating profit and net sales, which supports its long-term growth potential.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has seen a decline of 1.36% over the past week, while Jagsonpal Pharmaceuticals has increased by 7.66% in the same timeframe. This suggests that the stock has been relatively resilient compared to the overall market. However, the current decline may reflect profit-taking after a strong upward trend and increased investor participation, as indicated by a 230.1% rise in delivery volume. Despite the short-term drop, the company's low debt-to-equity ratio and consistent positive quarterly results indicate a solid foundation for future growth, which may help stabilize the stock in the long run.